Fay Stetner

1.8k total citations
10 papers, 1.4k citations indexed

About

Fay Stetner is a scholar working on Physiology, Molecular Biology and Applied Psychology. According to data from OpenAlex, Fay Stetner has authored 10 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 4 papers in Molecular Biology and 4 papers in Applied Psychology. Recurrent topics in Fay Stetner's work include Smoking Behavior and Cessation (9 papers), Behavioral Health and Interventions (4 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Fay Stetner is often cited by papers focused on Smoking Behavior and Cessation (9 papers), Behavioral Health and Interventions (4 papers) and Nicotinic Acetylcholine Receptors Study (4 papers). Fay Stetner collaborates with scholars based in United States and Canada. Fay Stetner's co-authors include Lirio S. Covey, Alexander H. Glassman, Sarah K. Rivelli, Gregory W. Dalack, A H Glassman, Julia C. Becker, Joseph L. Fleiss and Kurt Bjerregaard Stage and has published in prestigious journals such as The Lancet, American Journal of Psychiatry and Clinical Pharmacology & Therapeutics.

In The Last Decade

Fay Stetner

10 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fay Stetner United States 9 1.0k 441 308 245 227 10 1.4k
James E. Grobe United States 28 1.1k 1.0× 704 1.6× 514 1.7× 192 0.8× 205 0.9× 42 1.8k
Diane T. Hartz United States 9 610 0.6× 237 0.5× 230 0.7× 183 0.7× 179 0.8× 9 923
Marc L. Steinberg United States 21 918 0.9× 194 0.4× 356 1.2× 292 1.2× 236 1.0× 63 1.6k
Ellen S. Burgess United States 16 718 0.7× 144 0.3× 416 1.4× 497 2.0× 207 0.9× 22 1.9k
Jacques Le Houezec France 18 664 0.7× 302 0.7× 212 0.7× 82 0.3× 213 0.9× 31 1.1k
L Dahlgren Sweden 11 472 0.5× 290 0.7× 96 0.3× 214 0.9× 101 0.4× 20 1.2k
Peter Gariti United States 20 549 0.5× 214 0.5× 239 0.8× 176 0.7× 174 0.8× 35 1.1k
John R. Hughes United States 12 479 0.5× 176 0.4× 152 0.5× 102 0.4× 195 0.9× 12 1.1k
Suzan E. Winders United States 13 684 0.7× 255 0.6× 154 0.5× 207 0.8× 373 1.6× 20 1.1k
Joel D. Killen United States 11 510 0.5× 181 0.4× 237 0.8× 367 1.5× 348 1.5× 11 1.0k

Countries citing papers authored by Fay Stetner

Since Specialization
Citations

This map shows the geographic impact of Fay Stetner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fay Stetner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fay Stetner more than expected).

Fields of papers citing papers by Fay Stetner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fay Stetner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fay Stetner. The network helps show where Fay Stetner may publish in the future.

Co-authorship network of co-authors of Fay Stetner

This figure shows the co-authorship network connecting the top 25 collaborators of Fay Stetner. A scholar is included among the top collaborators of Fay Stetner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fay Stetner. Fay Stetner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Covey, Lirio S., Alexander H. Glassman, Fay Stetner, Sarah K. Rivelli, & Kurt Bjerregaard Stage. (2002). A Randomized Trial of Sertraline as a Cessation Aid for Smokers With a History of Major Depression. American Journal of Psychiatry. 159(10). 1731–1737. 71 indexed citations
2.
Glassman, Alexander H., Lirio S. Covey, Fay Stetner, & Sarah K. Rivelli. (2001). Smoking cessation and the course of major depression: a follow-up study. The Lancet. 357(9272). 1929–1932. 295 indexed citations
3.
Covey, Lirio S., Alexander H. Glassman, & Fay Stetner. (1999). Naltrexone Effects on Short-Term and Long-Term Smoking Cessation. Journal of Addictive Diseases. 18(1). 31–40. 88 indexed citations
4.
Covey, Lirio S., et al.. (1998). Cigarette Smoking and Major Depression. Journal of Addictive Diseases. 17(1). 35–46. 228 indexed citations
5.
Covey, Lirio S., Alexander H. Glassman, & Fay Stetner. (1997). Major depression following smoking cessation. American Journal of Psychiatry. 154(2). 263–265. 201 indexed citations
6.
Dalack, Gregory W., Alexander H. Glassman, Sarah K. Rivelli, Lirio S. Covey, & Fay Stetner. (1995). Mood, major depression, and fluoxetine response in cigarette smokers. American Journal of Psychiatry. 152(3). 398–403. 57 indexed citations
7.
Glassman, Alexander H., Lirio S. Covey, Gregory W. Dalack, et al.. (1993). Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clinical Pharmacology & Therapeutics. 54(6). 670–679. 134 indexed citations
8.
Covey, Lirio S., A H Glassman, Fay Stetner, & Julia C. Becker. (1993). Effect of history of alcoholism or major depression on smoking cessation. American Journal of Psychiatry. 150(10). 1546–1547. 88 indexed citations
9.
Glassman, A H, Lirio S. Covey, Gregory W. Dalack, & Fay Stetner. (1992). CIGARETTE SMOKING, MAJOR DEPRESSION, AND SCHIZOPHRENIA. Clinical Neuropharmacology. 15. 560A–561A. 6 indexed citations
10.
Covey, Lirio S., Alexander H. Glassman, & Fay Stetner. (1990). Depression and depressive symptoms in smoking cessation. Comprehensive Psychiatry. 31(4). 350–354. 278 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026